The PCOS group exhibited elevated anti-Müllerian hormone (AMH) levels, an increased LH/FSH ratio, irregular menstrual cycles, and a trend toward higher testosterone levels, consistent with typical clinical features of PCOS. This evidence concerns the gene BRD2 and polycystic ovary syndrome.